Clinical outcomes of living and deceased donor kidney transplants
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study looks at how well kidney transplants work from both living and deceased donors. It may help doctors better understand long-term outcomes for people who get a new kidney.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have received a kidney transplant from any donor (living or deceased).
- You agree to take part in the study and allow your data to be used.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines all kidneys donated from deceased donors (brain death or circulatory death) between 2010 and 2025 to understand how they are used for transplantation. It may help improve future transplant practices.
This study follows liver transplant recipients and living donors over time to track their health outcomes. It aims to understand their recovery and long-term wellbeing.
This study follows people who are planning kidney donation or a kidney transplant to better understand how kidney function changes over time. It may help researchers predict risk and improve care by studying health markers in detail.
This trial collects and stores health information and samples related to kidney transplants from both donors and recipients. It may help researchers better understand transplant outcomes and improve care in the future.
This trial is testing a way to help your body accept a kidney transplant without needing lifelong anti-rejection drugs. It is for people getting a kidney from a living donor who is a relative and has a compatible blood type.
This study looks at how well donor hearts work and how that affects outcomes after heart transplantation. It may help transplant teams choose and use donor hearts more effectively.
Hear when a new Transplant Recipient (Kidney) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.